Antidepressants and pregnancy: Women must consider the impact of drugs on baby, and of depression on baby, themselves
February 10, 2012 By Alexia Elejalde-Ruiz in Obstetrics & gynaecologyUpon learning they are pregnant, most women dutifully nix the alcohol, sushi and caffeine. But what about antidepressants?
Headlines about the potential risks of antidepressants on a developing fetus, including miscarriage, premature birth and newborn breathing problems, have produced angst for many moms on medication. But of greater concern, some experts say, are the harmful effects of untreated depression on the baby, including low birth weight, irritability and developmental delays.
"There's no path that's really risk-free," said Pec Indman, a San Jose, Calif.-based therapist who specializes in perinatal mood and anxiety disorders. "Illness has risk, and treatment has risk."
Which is riskier, of course, is the tough question.
Dozens of studies exploring the safety of antidepressants during pregnancy, especially the popular class of antidepressants known as selective serotonin reuptake inhibitors, or SSRIs, have yielded mixed results and suffered from design limitations.
A chief limitation is that it's not clear whether adverse outcomes are the fault of the medication or the depression itself, said Dr. Kimberly Yonkers, professor of psychiatry and of obstetrics, gynecology and reproductive services at Yale School of Public Health.
So far the most consistent data have linked antidepressants with preterm delivery, though studies haven't shown any long-term effects on the child, Yonkers said. A study last year that linked antidepressant use in the first trimester with a fourfold increase in the chance of a child having autism was met with a flurry of warnings from experts to not read into the findings, as it was the first and only study to make the association and there were methodological weaknesses.
One of the more common consequences of antidepressant exposure to babies is post-delivery withdrawal-like symptoms, including tremors, respiratory problems, feeding difficulties and jitteriness. In a 2006 Israeli study published in the Archives of Pediatric and Adolescent Medicine, a third of the antidepressant-exposed babies experienced such symptoms, compared with none in the control group, though most symptoms resolved themselves within a few days.
Other potential dangers pose a very small risk.
Writing last month in the British Medical Journal, European researchers found that taking SSRIs during the second half of pregnancy can more than double the risk that newborns will develop persistent pulmonary hypertension, a condition that prevents babies from getting enough oxygen into their bloodstream and, if severe, can result in multiple organ damage and death.
But that means the risk jumps from 1.2 in 1,000 babies to 3 in 1,000 babies, which is still very rare.
To compare, the risk of any woman developing a blood clot during pregnancy is 2 in 1,000 and of having a stillbirth is 6 in 1,000, said Dr. Avi Patil, who specializes in maternal-fetal medicine at Duke University Medical Center.
"Many more women will have depression in pregnancy that needs to be treated than will have this adverse event," said Patil, who in December published a review article in the journal Obstetrical and Gynecological Survey examining data on common antidepressants taken during pregnancy.
Left untreated, depression itself could harm gestating babies. Babies born to depressed moms have shown elevated cortisol levels and reduced serotonin levels, plus depressed moms are less likely to seek regular prenatal care or take prenatal vitamins and more likely to smoke or drink alcohol, Indman said. They also are more likely to experience postpartum depression, hampering their ability to interact with their new baby, which can interfere with development.
Studies have associated depressed moms with preterm delivery, low birth weight and low Apgar scores (a test to measure the health of a newborn). Untreated anxiety has been linked to babies with inconsolable crying, sleep problems and developmental delays, Indman said.
Women with mild depression might consider gradually tapering off their medication dose before they conceive (if they have the luxury of planning) or in the third trimester (if they don't) to decrease the risk of withdrawal symptoms in the newborn, Patil said. But if it's likely the mom will relapse, it's best to stay on. He recommends patients seek guidance from their OB-GYN and mental health providers to determine the best course of action, including alternative therapies.
It's never a good idea to discontinue medication abruptly. In a 2000 study of women who stopped taking antidepressants and anti-anxiety pills upon learning they were pregnant, 70 percent reported adverse physical or psychological effects, 30 percent had suicidal thoughts and 10 percent were admitted to hospitals.
"It was pretty sad," said study co-author Adrienne Einarson, a nurse who has published extensively on the topic. "It can be more harmful for women not to be treated, but no one seems to look at it that way."
Einarson, who is semiretired as assistant director of Motherisk, a counseling service for pregnant women based at The Hospital for Sick Children in Toronto, worries the stigma and misinformation about the risks might dissuade women from taking medication they need. Injury lawyers haven't helped; last year, a family won a $2.5 million settlement from GlaxoSmithKline after a jury found it negligent for not warning the mom's physician of the risks of taking Paxil during her pregnancy. Her son was born with a heart defect.
Several studies have linked paroxetine, the generic form of Paxil, to heart malformations, but others have found no greater risk, Einarson said.
"Now they're going to think for the rest of their lives that it was her fault because she took Paxil," she said.
More information: Resources: postpartum.net; womensmentalhealth.org
(c)2012 the Chicago Tribune
Distributed by MCT Information Services
-
Stopping meds during pregnancy does not increase risk of depression
Sep 09, 2011 |
not rated yet |
0
-
Antidepressant use during pregnancy associated with some adverse outcomes in newborns
Oct 05, 2009 |
not rated yet |
0
-
Exposure to certain antidepressants in pregnancy may modestly increase risk of autism spectrum disorders
Jul 04, 2011 |
not rated yet |
0
-
Antidepressants in pregnancy increase risk of miscarriage
May 31, 2010 |
not rated yet |
0
-
Pre-Existing hypertension linked to depression in pregnant women
Nov 11, 2011 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
May 25, 2012 |
4.5 / 5 (2) |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Theoretical highest electric charge?
3 hours ago
-
Effect of Damping wave on vibration
3 hours ago
-
How does impulse relate to energy when the net force is zero?
4 hours ago
-
Calculating Saturation Vapor Pressure?
11 hours ago
-
Question about high electric charge.
16 hours ago
-
eyeglasses with smallest chromatic abberation
19 hours ago
- More from Physics Forums - Classical Physics
More news stories
Phone contact with nurses linked with better outcomes for women with gestational diabetes
Among women with gestational diabetes mellitus, referral to a telephone-based nurse management program was associated with lower risk of high baby birth weight and increased postpartum glucose testing, according to Kaiser ...
Obstetrics & gynaecology
May 25, 2012 |
not rated yet |
0
Progestin treatment for polycystic ovarian syndrome may reduce pregnancy chances
(Medical Xpress) -- The hormone progestin, often given as a first step in infertility treatment for polycystic ovary syndrome (PCOS), appears to decrease the odds of conception and of giving birth, according to a study by ...
Obstetrics & gynaecology
May 25, 2012 |
not rated yet |
0
|
Women trying to have babies face different clock problem
A new Northwestern University study shows that the biological clock is not the only clock women trying to conceive should consider. The circadian clock needs attention, too.
Obstetrics & gynaecology
May 23, 2012 |
not rated yet |
0
|
UK may allow IVF for older women, same-sex couples
(AP) -- A powerful health advisory agency says Britain should extend free fertility treatments to women up to age 42 as well as same-sex couples, recommendations likely to be followed by many of the U.K.'s medical centers.
Obstetrics & gynaecology
May 22, 2012 |
not rated yet |
0
The Women's Health Initiative study and hormone therapy -- what have we learned 10 years on?
In July 2002 the publication of the first Women's Health Initiative (WHI) report caused a dramatic drop in Menopausal Hormone Therapy (HT ) use throughout the world. Now a major reappraisal by international experts, published ...
Obstetrics & gynaecology
May 22, 2012 |
not rated yet |
0
T cells 'hunt' parasites like animal predators seek prey, study shows
By pairing an intimate knowledge of immune-system function with a deep understanding of statistical physics, a cross-disciplinary team at the University of Pennsylvania has arrived at a surprising finding: T cells use a movement ...
Same gene that stunts infants' growth also makes them grow too big: research
UCLA geneticists have identified the mutation responsible for IMAGe* syndrome, a rare disorder that stunts infants' growth. The twist? The mutation occurs on the same gene that causes Beckwith-Wiedemann syndrome, which makes ...
Almost half of new vets seek disability
(AP) -- America's newest veterans are filing for disability benefits at a historic rate, claiming to be the most medically and mentally troubled generation of former troops the nation has ever seen.
Color-changing contact lenses to help diabetics (w/ Video)
For the millions of Americans with diabetes, the inconvenient and often painful method of testing blood sugar levels is a way of life. But research and innovative product design by scientists at The University of Akron may ...
Missouri opts for untested drug for executions
(AP) -- The same anesthetic that caused the overdose death of pop star Michael Jackson is now the drug of choice for executions in Missouri, causing a stir among critics who question how the state can guarantee ...
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.